Trials / Not Yet Recruiting
Not Yet RecruitingNCT07373613
A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
A Randomized, Multi-center, Double-Blind, Controlled, Parallel Design, Phase II Study to Evaluate the Efficacy and Safety Administration by Doses of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- Sponsor
- Boryung Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this clinical trial is to evaluate the antihypertensive efficacy and safety of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 with essential hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BR1400-1 | One tablet administered alone |
| DRUG | BR1400-2 | One tablet administered alone |
| DRUG | BR1400-3 | One tablet administered alone |
| DRUG | BR1400-4 | One tablet administered alone |
| DRUG | BR1400-5 | One tablet administered alone |
| DRUG | BR1400-A | One tablet administered alone |
| DRUG | BR1400-B | One tablet administered alone |
| DRUG | BR1400-C | One tablet administered alone |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2026-01-28
- Last updated
- 2026-01-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07373613. Inclusion in this directory is not an endorsement.